Should Methoxytyramine Routinely Be Included in the Guidelines for Biochemical Assessment of Pheochromocytomas and Paragangliomas?

• Ann T. Sweeney, MD,
• Michael A. Blake, MB, BCh,
• Sina Jasim, MD, MPH,
• Karel Pacak, MD, PhD, DSc

Affiliations

Ann T. Sweeney, MD

Division of Endocrinology, Department of Medicine, St Elizabeth’s Medical Center, Brighton, Massachusetts

Michael A. Blake, MB, BCh

Division of Abdominal Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts

Sina Jasim, MD, MPH

Division of Endocrinology, Metabolism, and Lipid Research, Washington University in St, Louis, School of Medicine St. Louis, Missouri

Karel Pacak, MD, PhD, DSc

Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Maryland; AKESO, Prague, Czech Republic